understanding glaucoma

What is open-angle glaucoma?

Open-angle glaucoma occurs when the fluid in one or both of your eyes does not drain properly. It increases the pressure in your eye, which can damage the optic nerve.

If left untreated, open-angle glaucoma is an eye disease that gradually causes vision loss.

While there is no way to reverse vision loss, early detection and treatment can help preserve sight.

Eye With Glaucoma

Drainage Canal Blocked

Increased Pressure

Damage to the Optic Nerve

Have open-angle glaucoma? You’re not alone.

Open-angle glaucoma:

  • Is the most common form of glaucoma
  • Affects more than 44 million people globally
  • Does not have any early warning signs or symptoms
  • Causes a slow loss in peripheral (side) vision

If left untreated, people with glaucoma may develop a visual disability and, eventually, blindness.

Normal vision

Vision with glaucoma

My doctor says I have OH, not glaucoma. What is OH?

Ocular hypertension (OH):

  • Is the medical term used when the pressure in the eye is higher than normal
  • Is caused when the fluid in the eye does not drain properly
  • Usually has no signs or symptoms but can be detected via routine testing by an eye care professional 
  • Can increase the risk of glaucoma and should be monitored carefully
  • Lowering eye pressure in people with glaucoma may slow or prevent vision loss.

Decreasing the pressure in the eye reduces the risk of vision loss from glaucoma.

INDICATION

VYZULTA (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.

IMPORTANT SAFETY INFORMATION 
  • Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.
  • Gradual changes to eyelashes may occur, including increased length, thickness, color, number of eyelashes and/or direction of eyelash growth. These changes may result in a difference in appearance of each eye. These changes are usually reversible after VYZULTA treatment is discontinued.
  • Avoid touching the tip of the container to the eye or any other surface, including a finger, in order to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions.
  • Tell your doctor immediately about any change in your eye, any eye condition that develops, any sudden change in your vision, any eye side effects, or if you have eye surgery.
  • Remove contact lenses before putting VYZULTA in your eyes. Lenses may be reinserted 15 minutes later.
  • If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop.
  • The most common side effects seen in studies were eye redness, eye irritation, eye pain, and pain after putting the drops in your eye.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

SEE MORE

INDICATION

VYZULTA (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension.

IMPORTANT SAFETY INFORMATION 
  • Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued.